SP

Sadanand Prasad

Active Director Director DIN 09111592
DIN 09111592 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Sadanand Prasad

Data last updated:

Sadanand Prasad is a Director at Hanusha Pharma Private Limited (since 2021). The company operates in Pharma. Hanusha Pharma Private Limited reported revenue of ₹27.9 Lakh (FY 2024).

DIN 09111592
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2021
Oldest Company Age 8 yrs
Largest company Hanusha Pharma Private Limited · ₹27.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hanusha Pharma Private Limited U85300DL2018PTC329562
Director18 Mar 20212018₹27.9 Lakh (FY 2024)Active

Board colleagues of Sadanand Prasad

NameDINCompanyDesignation
Sumita Suman08056179Hanusha Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hanusha Pharma Private Limited
Premium access

Shareholding and investment profile for Sadanand Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sadanand Prasad

Sadanand Prasad currently holds 1 directorship: Hanusha Pharma Private Limited (Director, since 18 Mar 2021, revenue ₹27.9 Lakh (FY 2024)).

Sadanand Prasad was first appointed on 18 Mar 2021 as Director at Hanusha Pharma Private Limited.

The current boards of Sadanand Prasad's companies include Sumita Suman (Hanusha Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available